VetViva Richter GmbH
ATBRA.591683-000
Headquarters
Durisolstraße 14
4600 Wels
Upper Austria
Austria
Contact
Management
Andreas Asamer
Managing Director
Since October 28, 2022
Bernd Follrich
Managing Director
Since April 1, 2023
Financials
| Year | Revenue | Earnings | Balance Total | Equity Ratio |
|---|---|---|---|---|
| 2024 | ~94.000.000 € | 2.696.655 € | 67.567.965 € | 33.6% |
| 2023 | ~100.000.000 € | -62.261 € | 58.585.663 € | 34.1% |
| 2022 | ~180.000 € | -1.000 € | 34.000 € | 100.0% |
Industry
NACE 21.20Manufacture of pharmaceutical preparationsISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Manufacture of pharmaceutical preparations
Raw Data
{
"id": "71346828-981c-4962-99ac-4626dce2e288",
"euId": "ATBRA.591683-000",
"name": "VetViva Richter GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "2022-10-18T00:00:00",
"vatId": null,
"hq": {
"line2": null,
"street": "Durisolstraße 14",
"city": "Wels",
"zipCode": "4600",
"state": "Upper Austria",
"country": "AT",
"latitude": 48.14888045,
"longitude": 14.006231373166177
},
"contactData": {
"emails": [
"office@vetviva.com"
],
"phones": [],
"websites": [
"https://vetviva.com/"
],
"faxes": []
},
"managers": [
{
"name": "Andreas Asamer",
"position": "Managing Director",
"startDate": "2022-10-28T00:00:00",
"endDate": null
},
{
"name": "Bernd Follrich",
"position": "Managing Director",
"startDate": "2023-04-01T00:00:00",
"endDate": null
}
],
"industry": {
"isic": [
"2100"
],
"nace": [
"21.20"
],
"nace2025": [
"21.20"
],
"naics": [
"325199",
"325411",
"325412",
"325413",
"325414",
"339113"
],
"uksic": [
"21.20"
],
"wz": []
},
"financials": [
{
"year": 2022,
"currency": "EUR",
"capital": 35000,
"capitalIsEstimate": false,
"balanceTotal": 34000,
"balanceTotalIsEstimate": false,
"earnings": -1000,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 180000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": -0.5555555555555556,
"returnOnSalesIsEstimate": true,
"equity": 34000,
"equityIsEstimate": false,
"equityRatio": 100,
"equityRatioIsEstimate": false,
"cash": 33000,
"cashIsEstimate": false,
"receivables": 0,
"receivablesIsEstimate": false,
"liabilities": 0,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 35000,
"capitalIsEstimate": false,
"balanceTotal": 58585662.64,
"balanceTotalIsEstimate": false,
"earnings": -62260.85,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 100000000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": -0.062260850000000006,
"returnOnSalesIsEstimate": true,
"equity": 19985263.91,
"equityIsEstimate": false,
"equityRatio": 34.11289214701967,
"equityRatioIsEstimate": false,
"cash": 43823.55,
"cashIsEstimate": false,
"receivables": 10575748.32,
"receivablesIsEstimate": false,
"liabilities": 35979272.05,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 35000,
"capitalIsEstimate": false,
"balanceTotal": 67567964.59,
"balanceTotalIsEstimate": false,
"earnings": 2696655.39,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 94000000,
"revenueIsEstimate": true,
"revenueCagr": 2185.2182001336814,
"revenueCagrIsEstimate": true,
"returnOnSales": 2.8687823297872344,
"returnOnSalesIsEstimate": true,
"equity": 22681919.3,
"equityIsEstimate": false,
"equityRatio": 33.56904331458418,
"equityRatioIsEstimate": false,
"cash": 1397695.07,
"cashIsEstimate": false,
"receivables": 8424242.82,
"receivablesIsEstimate": false,
"liabilities": 42512821.39,
"liabilitiesIsEstimate": false
}
]
}